DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 146 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $766,101 | +285.0% | 72,002 | +276.9% | 0.00% | – |
| Q3 2022 | $199,000 | -24.0% | 19,106 | -7.9% | 0.00% | -100.0% |
| Q2 2022 | $262,000 | +61.7% | 20,747 | +38.3% | 0.00% | – |
| Q1 2022 | $162,000 | -80.4% | 15,000 | -74.5% | 0.00% | -100.0% |
| Q4 2021 | $828,000 | -78.2% | 58,900 | -70.2% | 0.00% | -85.7% |
| Q3 2021 | $3,798,000 | +235.8% | 197,700 | +72.2% | 0.01% | +250.0% |
| Q2 2021 | $1,131,000 | -4.5% | 114,800 | -4.7% | 0.00% | -20.0% |
| Q1 2021 | $1,184,000 | +1615.9% | 120,464 | +682.2% | 0.01% | – |
| Q4 2020 | $69,000 | -14.8% | 15,400 | -18.1% | 0.00% | – |
| Q3 2020 | $81,000 | -46.0% | 18,800 | +10.9% | 0.00% | -100.0% |
| Q2 2020 | $150,000 | -45.8% | 16,945 | -75.6% | 0.00% | -50.0% |
| Q2 2019 | $277,000 | +5.3% | 69,372 | +141.7% | 0.00% | 0.0% |
| Q4 2018 | $263,000 | +26200.0% | 28,700 | +60963.8% | 0.00% | – |
| Q3 2015 | $1,000 | -99.7% | 47 | -99.7% | 0.00% | -100.0% |
| Q1 2015 | $309,000 | – | 13,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |